148 related articles for article (PubMed ID: 31463900)
1. Analyzing the Effects of O-Fucosylation on Secretion of ADAMTS Proteins Using Cell-Based Assays.
Berardinelli SJ; Haltiwanger RS
Methods Mol Biol; 2020; 2043():25-43. PubMed ID: 31463900
[TBL] [Abstract][Full Text] [Related]
2. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism.
Vasudevan D; Takeuchi H; Johar SS; Majerus E; Haltiwanger RS
Curr Biol; 2015 Feb; 25(3):286-295. PubMed ID: 25544610
[TBL] [Abstract][Full Text] [Related]
3. O-fucosylation stabilizes the TSR3 motif in thrombospondin-1 by interacting with nearby amino acids and protecting a disulfide bond.
Berardinelli SJ; Eletsky A; Valero-González J; Ito A; Manjunath R; Hurtado-Guerrero R; Prestegard JH; Woods RJ; Haltiwanger RS
J Biol Chem; 2022 Jun; 298(6):102047. PubMed ID: 35597280
[TBL] [Abstract][Full Text] [Related]
4.
Zhang A; Berardinelli SJ; Leonhard-Melief C; Vasudevan D; Liu TW; Taibi A; Giannone S; Apte SS; Holdener BC; Haltiwanger RS
J Biol Chem; 2020 Nov; 295(46):15742-15753. PubMed ID: 32913123
[No Abstract] [Full Text] [Related]
5. ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.
Holdener BC; Percival CJ; Grady RC; Cameron DC; Berardinelli SJ; Zhang A; Neupane S; Takeuchi M; Jimenez-Vega JC; Uddin SMZ; Komatsu DE; Honkanen R; Dubail J; Apte SS; Sato T; Narimatsu H; McClain SA; Haltiwanger RS
Hum Mol Genet; 2019 Dec; 28(24):4053-4066. PubMed ID: 31600785
[TBL] [Abstract][Full Text] [Related]
6. O-fucosylation of thrombospondin type I repeats is dispensable for trafficking thrombospondin 1 to platelet secretory granules.
Berardinelli SJ; Sillato AR; Grady RC; Neupane S; Ito A; Haltiwanger RS; Holdener BC
Glycobiology; 2023 May; 33(4):301-310. PubMed ID: 36721988
[TBL] [Abstract][Full Text] [Related]
7. Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase.
Zhang A; Venkat A; Taujale R; Mull JL; Ito A; Kannan N; Haltiwanger RS
J Biol Chem; 2021 Jul; 297(1):100843. PubMed ID: 34058199
[TBL] [Abstract][Full Text] [Related]
8. O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1 regulates secretion: implications for the ADAMTS superfamily.
Wang LW; Dlugosz M; Somerville RP; Raed M; Haltiwanger RS; Apte SS
J Biol Chem; 2007 Jun; 282(23):17024-31. PubMed ID: 17395588
[TBL] [Abstract][Full Text] [Related]
9. O-fucosylation of thrombospondin type 1 repeats is essential for ECM remodeling and signaling during bone development.
Neupane S; Berardinelli SJ; Cameron DC; Grady RC; Komatsu DE; Percival CJ; Takeuchi M; Ito A; Liu TW; Nairn AV; Moremen KW; Haltiwanger RS; Holdener BC
Matrix Biol; 2022 Mar; 107():77-96. PubMed ID: 35167946
[TBL] [Abstract][Full Text] [Related]
10. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.
Dubail J; Vasudevan D; Wang LW; Earp SE; Jenkins MW; Haltiwanger RS; Apte SS
Sci Rep; 2016 Sep; 6():33974. PubMed ID: 27687499
[TBL] [Abstract][Full Text] [Related]
11. 6-alkynyl fucose is a bioorthogonal analog for O-fucosylation of epidermal growth factor-like repeats and thrombospondin type-1 repeats by protein O-fucosyltransferases 1 and 2.
Al-Shareffi E; Chaubard JL; Leonhard-Melief C; Wang SK; Wong CH; Haltiwanger RS
Glycobiology; 2013 Feb; 23(2):188-98. PubMed ID: 23045360
[TBL] [Abstract][Full Text] [Related]
12. Genetic and biochemical evidence that gastrulation defects in Pofut2 mutants result from defects in ADAMTS9 secretion.
Benz BA; Nandadasa S; Takeuchi M; Grady RC; Takeuchi H; LoPilato RK; Kakuda S; Somerville RPT; Apte SS; Haltiwanger RS; Holdener BC
Dev Biol; 2016 Aug; 416(1):111-122. PubMed ID: 27297885
[TBL] [Abstract][Full Text] [Related]
13. Two distinct pathways for O-fucosylation of epidermal growth factor-like or thrombospondin type 1 repeats.
Luo Y; Nita-Lazar A; Haltiwanger RS
J Biol Chem; 2006 Apr; 281(14):9385-92. PubMed ID: 16464858
[TBL] [Abstract][Full Text] [Related]
14. Hydrocephalus in mouse B3glct mutants is likely caused by defects in multiple B3GLCT substrates in ependymal cells and subcommissural organ.
Neupane S; Goto J; Berardinelli SJ; Ito A; Haltiwanger RS; Holdener BC
Glycobiology; 2021 Sep; 31(8):988-1004. PubMed ID: 33909046
[TBL] [Abstract][Full Text] [Related]
15. Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells.
Lauwen S; Baerenfaenger M; Ruigrok S; de Jong EK; Wessels HJCT; den Hollander AI; Lefeber DJ
Exp Eye Res; 2021 Dec; 213():108798. PubMed ID: 34695439
[TBL] [Abstract][Full Text] [Related]
16.
Takeuchi H; Yu H; Hao H; Takeuchi M; Ito A; Li H; Haltiwanger RS
J Biol Chem; 2017 Sep; 292(38):15964-15973. PubMed ID: 28729422
[TBL] [Abstract][Full Text] [Related]
17.
Bandini G; Leon DR; Hoppe CM; Zhang Y; Agop-Nersesian C; Shears MJ; Mahal LK; Routier FH; Costello CE; Samuelson J
J Biol Chem; 2019 Feb; 294(6):1967-1983. PubMed ID: 30538131
[No Abstract] [Full Text] [Related]
18. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats.
Heinonen TY; Maki M
Ann Med; 2009; 41(1):2-10. PubMed ID: 18720094
[TBL] [Abstract][Full Text] [Related]
19. Structure of human POFUT2: insights into thrombospondin type 1 repeat fold and O-fucosylation.
Chen CI; Keusch JJ; Klein D; Hess D; Hofsteenge J; Gut H
EMBO J; 2012 Jul; 31(14):3183-97. PubMed ID: 22588082
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome.
Weh E; Takeuchi H; Muheisen S; Haltiwanger RS; Semina EV
PLoS One; 2017; 12(9):e0184903. PubMed ID: 28926587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
